Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JONATHAN W HODGSON

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1851345433
CMS profile
38154
Location
GILBERT, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$32,004.97

393 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Page 3 of 8; records 101–150 of 393 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JONATHAN W HODGSON

NPI 1851345433 · CMS profile ID 38154

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

GILBERT, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 8; records 101–150 of 393 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1851345433?year=2023&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JONATHAN W HODGSON, NPI 1851345433, CMS profile ID 38154. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 8; records 101–150 of 393 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1851345433?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). JONATHAN W HODGSON, NPI 1851345433, CMS profile ID 38154. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 8; records 101–150 of 393 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1851345433?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
JONATHAN W HODGSON, NPI 1851345433, CMS profile ID 38154, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 8; records 101–150 of 393 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1851345433?year=2023&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

393 matching records · $32,004.97 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 393 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 393.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Otsuka America Pharmaceutical, Inc. $6.5709/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014406349 CMS
Otsuka America Pharmaceutical, Inc. $21.3809/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014406339 CMS
UCB, Inc. $0.3709/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021382937 CMS
UCB, Inc. $6.8409/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021383027 CMS
UCB, Inc. $16.6709/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021383093 CMS
ARGENX US, INC. $25.0109/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060404421 CMS
Alexion Pharmaceuticals, Inc. $25.1409/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017068017 CMS
ABBVIE INC. $17.4409/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997487519 CMS
Lundbeck LLC $465.8009/24/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032242883 CMS
Lundbeck LLC $165.0009/24/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032242889 CMS
Lundbeck LLC $50.0009/23/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032242857 CMS
Lundbeck LLC $20.2209/23/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032242865 CMS
Lundbeck LLC $16.5709/23/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032242871 CMS
Lundbeck LLC $50.0009/23/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032242877 CMS
Lundbeck LLC $238.2609/22/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032242853 CMS
ABBVIE INC. $9.6209/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997487517 CMS
Lundbeck LLC $45.0009/21/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032242845 CMS
ABBVIE INC. $5.0909/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997487515 CMS
EMD Serono, Inc. $23.0609/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032402317 CMS
Novartis Pharmaceuticals Corporation $24.2609/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992178901 CMS
BANNER LIFE SCIENCES, LLC $0.7709/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021113913 CMS
BANNER LIFE SCIENCES, LLC $20.9109/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021113915 CMS
Novartis Pharmaceuticals Corporation $20.5709/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992178905 CMS
ABBVIE INC. $16.7809/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997487513 CMS
Genentech USA, Inc. $26.4509/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040409833 CMS
Lilly USA, LLC $19.1609/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031612551 CMS
Eisai Inc. $65.2109/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053715741 CMS
Otsuka America Pharmaceutical, Inc. $18.3809/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014406327 CMS
PFIZER INC. $5.3709/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050541743 CMS
Corium, LLC $13.7709/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 978391903 CMS
ABBVIE INC. $4.2509/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997487511 CMS
ABBVIE INC. $5.5609/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997487509 CMS
ACADIA Pharmaceuticals Inc $30.2009/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053137523 CMS
Lundbeck LLC $8.8709/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032242839 CMS
Merz Pharmaceuticals, LLC $25.6609/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048293715 CMS
Microtransponder, Inc. $14.3509/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997194073 CMS
PFIZER INC. $3.1309/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049106210 CMS
Lilly USA, LLC $17.5209/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031597679 CMS
ABBVIE INC. $19.9708/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997487507 CMS
Neurocrine Biosciences, Inc. $28.7608/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052043909 CMS
EMD Serono, Inc. $22.9108/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032373591 CMS
AstraZeneca Pharmaceuticals LP $21.1408/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014338977 CMS
Neurelis, Inc. $15.5608/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050919713 CMS
Teva Pharmaceuticals USA, Inc. $34.0608/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056794983 CMS
IMPEL PHARMACEUTICALS INC. $24.3508/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 989410891 CMS
Lundbeck LLC $60.0008/24/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032242833 CMS
Alexion Pharmaceuticals, Inc. $22.6108/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017062293 CMS
ABBVIE INC. $8.5708/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997487505 CMS
Otsuka America Pharmaceutical, Inc. $11.3208/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014406317 CMS
PFIZER INC. $6.1608/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049348095 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $23,800.31 335
PY2020 $53,074.73 253
PY2021 $89,831.28 362
PY2022 $69,439.77 417
PY2023 $32,004.97 393
PY2024 $71,362.13 316
PY2025 $68,604.78 185

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $275,701.83 25
PY2024 Principal investigator $214,356.31 16
PY2023 Recipient $372.40 1
PY2023 Principal investigator $264,058.35 10
PY2022 Recipient $1,630.00 2
PY2022 Principal investigator $343,018.65 15
PY2021 Recipient $2,855.10 1
PY2021 Principal investigator $243,879.56 6
PY2020 Recipient $14,577.94 3
PY2020 Principal investigator $22,051.00 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

25 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $600.00 12/31/2025 Non-covered Recipient Entity
QCARE SITE SERVICES INC
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Ubrogepant for the Preventive Treatment of Menstrual Migraine with an Open-Label Extension No dispute reported 06/30/2026 1202532685
Principal investigator 1 ABBVIE INC. $1,497.30 12/04/2025 Non-covered Recipient Entity
QCARE SITE SERVICES INC
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202526602
Principal investigator 1 ABBVIE INC. $3,381.00 12/04/2025 Non-covered Recipient Entity
QCARE SITE SERVICES INC
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202526604
Principal investigator 1 ABBVIE INC. $20,734.50 11/05/2025 Non-covered Recipient Entity
QCARE SITE SERVICES INC
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202521375
Principal investigator 1 ABBVIE INC. $510.60 11/04/2025 Non-covered Recipient Entity
QCARE SITE SERVICES INC
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202521219
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $200.50 10/27/2025 Non-covered Recipient Entity
Gilbert Neurology Partners Pllc
Phase III Safety and Efficacy of KarXT in Psychosis Associated with AD (ADEPT 4): 2 of 2 Acute Studies No dispute reported 06/30/2026 1235997089
Principal investigator 1 ABBVIE INC. $765.90 10/09/2025 Non-covered Recipient Entity
QCARE SITE SERVICES INC
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202514219
Principal investigator 1 ABBVIE INC. $21,583.20 10/09/2025 Non-covered Recipient Entity
QCARE SITE SERVICES INC
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202514225
Principal investigator 1 ABBVIE INC. $483.00 09/04/2025 Non-covered Recipient Entity
QCARE SITE SERVICES INC
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202509602
Principal investigator 1 ABBVIE INC. $7,555.50 08/06/2025 Non-covered Recipient Entity
QCARE SITE SERVICES INC
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202503565
Principal investigator 1 ABBVIE INC. $675.60 08/04/2025 Non-covered Recipient Entity
QCARE SITE SERVICES INC
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202501028
Principal investigator 1 ABBVIE INC. $1,792.80 07/09/2025 Non-covered Recipient Entity
QCARE SITE SERVICES INC
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202497678
Principal investigator 1 ABBVIE INC. $1,021.20 07/09/2025 Non-covered Recipient Entity
QCARE SITE SERVICES INC
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202497680
Principal investigator 1 ABBVIE INC. $1,005.60 07/08/2025 Non-covered Recipient Entity
QCARE SITE SERVICES INC
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202497478
Principal investigator 1 ABBVIE INC. $5,037.00 07/02/2025 Non-covered Recipient Entity
QCARE SITE SERVICES INC
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202496617
Principal investigator 1 ABBVIE INC. $11,888.70 06/12/2025 Non-covered Recipient Entity
QCARE SITE SERVICES INC
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202491141
Principal investigator 1 ABBVIE INC. $22,735.50 05/07/2025 Non-covered Recipient Entity
QCARE SITE SERVICES INC
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202482999
Principal investigator 1 ABBVIE INC. $330.00 05/06/2025 Non-covered Recipient Entity
QCARE SITE SERVICES INC
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202481599
Principal investigator 1 ABBVIE INC. $15,476.70 04/03/2025 Non-covered Recipient Entity
QCARE SITE SERVICES INC
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202472885
Principal investigator 1 ABBVIE INC. $14,441.70 03/07/2025 Non-covered Recipient Entity
COGNITIVE CLINICAL TRIALS LLC
M23-714 - Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202460359
Principal investigator 1 ABBVIE INC. $6,969.00 02/06/2025 Non-covered Recipient Entity
COGNITIVE CLINICAL TRIALS LLC
M23-714 - Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202447264
Principal investigator 1 Sage Therapeutics, LLC $18,550.60 01/31/2025 Non-covered Recipient Entity
COGNITIVE CLINICAL TRIALS, LLC
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease No dispute reported 06/30/2026 1206580750
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $5,269.83 01/27/2025 Non-covered Recipient Entity
Gilbert Neurology
A Randomized, Double-blind, Placebo-controlled, Global Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986446, an Anti-MTBR Tau Monoclonal Antibody, in Participants with Early Alzheimers Disease (TargetTau-1) No dispute reported 06/30/2026 1235997091
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $111,540.10 01/13/2025 Non-covered Recipient Entity
Gilbert Neurology
A Randomized, Double-blind, Placebo-controlled, Global Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986446, an Anti-MTBR Tau Monoclonal Antibody, in Participants with Early Alzheimers Disease (TargetTau-1) No dispute reported 06/30/2026 1235997093
Principal investigator 1 ABBVIE INC. $1,656.00 01/02/2025 Non-covered Recipient Entity
COGNITIVE CLINICAL TRIALS LLC
M23-714 - Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202433855